Cite
HARVARD Citation
Tan, A. et al. (2020). Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis. Lung cancer. pp. 207-215. [Online].